Effect of retention time on NMP22 bladder check assay results in voided urine

作者: Cosentino Marco , Villavicencio Humberto , Pascual Merce , Rodriguez Oscar , Caicedo Juan Ignacio

DOI:

关键词: UrologyCystoscopyUrineMedicineMorningResectionGynecologyBladder cancerRetention timeKowsarUrinary system

摘要: Background: Bladder cancer health care costs are high, primarily due to the need for long-term follow-up. Several markers have been developed detect presence of urothelial cell carcinoma (UCC) in urinary tract. These differing sensitivity and specificity. The nuclear matrix protein-22 (NMP22) test increases ability recurrent bladder cancer. Objectives: aim this study was evaluate possible changes results depending on length retention time collected urine. Patients Methods: Between January June 2006 we prospectively evaluated voided urine specimens 69 patients undergoing control cystoscopy or transurethral resection primary We tested NMP22 first morning sample samples after 5 min, 30 min 2 h bladder. Sensitivity, specificity, positive predictive value (PPV) negative (NPV) were determined, grouped according tumor stage grade. Results: Global similar all groups (first 5-min, 30-min 2-h retention); best observed at point (80%). Specificity varied from 75% 100% obtained h. PPV 95.5–100% different periods, while NPV range 27.3–33.3%. Conclusion: Although not a large series, it appears that there is tendency towards better with time. It necessary wait operability. ARTICLE INFO

参考文章(8)
A. Saad, D.C. Hanbury, T.A. McNicholas, G.B. Boustead, S. Morgan, A.C. Woodman, A STUDY COMPARING VARIOUS NONINVASIVE METHODS OF DETECTING BLADDER CANCER IN URINE BJUI. ,vol. 89, pp. 369- 373 ,(2002) , 10.1046/J.1464-4096.2001.01699.X
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes, Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer. European Urology. ,vol. 48, pp. 951- 956 ,(2005) , 10.1016/J.EURURO.2005.09.002
Susan K. Keesee, Joseph V. Briggman, Gregory Thill, Ying-Jye Wu, Utilization of Nuclear Matrix Proteins for Cancer Diagnosis Critical Reviews in Eukaryotic Gene Expression. ,vol. 6, pp. 189- 214 ,(1996) , 10.1615/CRITREVEUKARGENEEXPR.V6.I2-3.50
Marko Babjuk, Willem Oosterlinck, Richard Sylvester, Eero Kaasinen, Andreas Böhle, Juan Palou-Redorta, Morgan Rouprêt, EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update European Urology. ,vol. 59, pp. 997- 1008 ,(2011) , 10.1016/J.EURURO.2011.03.017
Samir P Shirodkar, Vinata B Lokeshwar, Potential new urinary markers in the early detection of bladder cancer. Current Opinion in Urology. ,vol. 19, pp. 488- 493 ,(2009) , 10.1097/MOU.0B013E32832EB3A0
H Barton Grossman, Mark Soloway, Edward Messing, Giora Katz, Barry Stein, Vahan Kassabian, Yu Shen, Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay JAMA. ,vol. 295, pp. 299- 305 ,(2006) , 10.1001/JAMA.295.3.299
Atul Kumar, Rajeev Kumar, Narmada P. Gupta, Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Japanese Journal of Clinical Oncology. ,vol. 36, pp. 172- 175 ,(2006) , 10.1093/JJCO/HYI244